Various forms of status spongiosus occur in neonatal cattle, the best characterized of which is due to mutations of the branched-chain alpha-keto acid dehydrogenase complex (BCKD), resulting in bovine maple syrup urine disease (MSUD, branched-chain ketoaciduria). A distinctive neurological syndrome was identified between 1998 and 2003 in 9 calves in a 250-cow stabilized Gelbvieh-Red Angus herd. Both sexes were affected (6 heifers, 3 bulls), with a low annual incidence (3 cases in 1998; no cases in 1999; 2 cases in 2000; 2 in 2001; 1 in 2002; 1 in 2003). Affected calves were born full-term, unable to stand, and had constant whole-body tremors when stimulated. Animals remained in lateral recumbency until death or euthanasia; the longest survival time was 10 days postpartum. The principal histological change in 2 affected calves was diffuse, moderately severe bilaterally symmetrical status spongiosus with Alzheimer type II cells throughout the white matter of the brain. Myelin deficits were not evident and vacuoles were due to cleaved myelin sheaths. Neither recognized mutation of MSUD was identified in the E1a subunit of BCKD in 2 affected calves, 8 dams that gave birth to affected calves, a grand-dam of 3 affected calves, or a sire of 1 calf. Amino acid analysis of serum from 1 affected calf revealed normal concentrations of branched-chain amino acids, indicating that this disease is distinct from MSUD. The genetic and biochemical basis for the disorder, provisionally named congenital status spongiosus of Gelbvieh-cross cattle, is undetermined. The pattern of inheritance was not established.
AdachiMSchneckLCaraJVolkBW: 1973, Spongy degeneration of the central nervous system (van Bogaert and Bertrand type; Canavan's disease). A review. Hum Pathol4: 331–347.
2.
AdornatoBTO'BrienJSLampertPW: 1972, Cerebral spongy degeneration of infancy. A biochemical and ultrastructural study of affected twins. Neurology22: 202–210.
3.
BairdJDWojcinskiZCWiseAPGodkinMA: 1987, Maple syrup urine disease in five Hereford calves in Ontario. Can Vet J28: 505–511.
4.
BancroftJDGambleM: 2002, Theory and practice of histological techniques, 5th ed., pp. 376–377, 385. Churchill Livingstone, London, UK.
5.
BankerBQRobertsonJTVictorM: 1964, Spongy degeneration of the central nervous system in infancy. Neurology14: 981–1001.
6.
BeaudetAL: 2001, Aspartoacylase deficiency (Canavan disease). In: The metabolic and molecular bases of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 8th ed., pp. 5799–5805. McGraw-Hill, New York, NY.
7.
BeckerLEPriorTWYatesAJ: 1997, Metabolic diseases. In: Textbook of neuropathology, eds. DavisRLRobertsonDM, 3rd ed., pp. 469–471. Williams and Wilkins, Baltimore, MD.
8.
ChaungDTShihVE: 2001, Maple syrup urine disease (branched-chain ketoaciduria). In: The metabolic and molecular bases of inherited diseases, eds. ScriverCRBeaudetALSlyWSValleD, 8th ed., pp. 1971–2005. McGraw-Hill, New York, NY.
9.
CorderoMETrejoMColomboMArandaV: 1983, Histological maturation of the neocortex in phenylketonuric rats. Early Human Dev8: 157–173.
CornishTEvan OlphenALCavenderJL: 2005, Comparison of ear notch immunohistochemistry, ear notch antigen capture ELISA, and buffy coat virus isolation for detection of calves persistently infected with bovine viral diarrhea virus. J Vet Diagn Invest17: 110–117.
12.
DennisJAHealyPJ: 1999, Definition of the mutation responsible for maple syrup urine disease in Poll Shorthorns and genotyping of Poll Shorthorns and Poll Herefords for maple syrup urine disease alleles. Res Vet Sci67: 1–6.
13.
DuffellSJ: 1986, Neuraxial oedema of Hereford calves with and without hypomyelinogenesis. Vet Rec118: 95–98.
14.
DuffellSJHarperPAHealyPJDennisJA: 1988, Congenital hypomyelinogenesis of Hereford calves. Vet Rec123: 423–424.
15.
GraeberMBBlakemoreWFKreutzbergGW: 2002, Cellular pathology of the central nervous system. In: Greenfield's neuropathology, 7th ed., eds. GrahamDILantosPL, pp. 148–150. Arnold, London, UK.
16.
HagenGBjerkåsI: 1990, Spongy degeneration of white matter in the central nervous system of silver foxes (Vulpes vulpes). Vet Pathol27: 187–193.
17.
HardingBNSurteesR: 2002, Metabolic and neurodegenerative diseases of childhood. In: Greenfield's neuropathology, 7th ed., eds. GrahamDILantosPL, pp. 494–495, 501–511. Arnold, London, UK.
18.
HarperPAWDennisJAHealyPJBrownGK: 1989, Maple syrup urine disease in calves: A clinical, pathological and biochemical study. Aust Vet J66: 46–49.
19.
HarperPAWHealyPJDennisJA: 1986, Maple syrup urine disease as a cause of spongiform encephalopathy in calves. Vet Rec119: 62–65.
20.
HarperPAWHealyPJDennisJA: 1986, Ultrastructural findings in maple syrup urine disease in Poll Hereford calves. Acta Neuropathol71: 316–320.
21.
HealyPJDennisJA: 1994, Molecular heterogeneity for bovine maple syrup urine disease. Anim Genet25: 329–332.
22.
HealyPJDennisJA: 1995, Heterozygote detection for maple syrup urine disease in cattle. Aust Vet J72: 346–348.
23.
HealyPJDennisJAWindsorPA: 2002, Genotyping cattle for inherited congenital myoclonus and maple syrup urine disease. Aust Vet J80: 695–697.
24.
HealyPJHarperPAWDennisJA: 1986, Diagnosis of neuraxial edema in calves. Aust Vet J63: 95.
25.
InnesJRMSaundersLZ: 1962, Congenital ataxia in Jersey calves (and Angus–Shorthorns)–-a leucodysplasia of cerebellum, midbrain and medulla. In: Comparative neuropathology, pp. 308–311. Academic Press, New York, NY, and London, UK.
KitadaKAkimitsuTShigematsuY: 2000, Accumulation of N-acetyl-L-aspartate in the brain of the tremor rat, a mutant exhibiting absence-like seizure and spongiform degeneration in the central nervous system. J Neurochem74: 2512–2519.
28.
KondoASuzukiK: 1993, The blood brain barrier in human leukodystrophies and allied diseases. Ultrastructural and morphometric studies on the capillaries in brain biopsies. Clin Neuropathol12: 169–174.
MatalonRMMichals-MatalonK: 2000, Spongy degeneration of the brain, Canavan disease: Biochemical and molecular findings. Front Biosci5: D307–D311.
31.
MenkesJHHurstPLCraigJM: 1954, A new syndrome: Progressive familial infantile cerebral dysfunction associated with an unusual urinary substance. Pediatrics14: 462–467.
32.
MontgomeryDL: 1994, Astrocytes: Form, functions, and roles in disease. Vet Pathol31: 145–167.
33.
MundayBLMasonRWHartleyWS: 1976, Encephalopathies in cattle in Tasmania. Aust Vet J52: 92–96.
34.
PodebradPHeilMReichertS: 1999, 4,5-Dimethyl-3-hydroxy-2[5H]-furanone (sotolone)–-the odour of maple syrup urine disease. J Inherited Metabolic Dis22: 107–114.
35.
PowersJMDe VivoDC: 2002, Peroxisomal and mitochondrial disorders. In: Greenfield's neuropathology, 7th ed., eds. GrahamDILantosPL, pp. 743–745. Arnold, London, UK.
36.
SummersBACummingsJFde LahuntaA: 1995, Degenerative diseases of the central nervous system. In: Veterinary neuropathology, pp. 295–299. Mosby, St. Louis, MO.
37.
SurendranSMichals-MatalonKQuastMJ: 2003, Canavan disease: A monogenic trait with complex genomic interaction. Mol Genet Metab80: 74–80.
38.
WestallRGDancisJMillerS: 1957, Maple syrup urine disease. Am J Dis Child94: 571–572.
39.
WoodSLPattersonJS: 2001, Shetland sheepdog leukodystrophy. J Vet Intern Med15: 486–493.
ZacharyJFO'BrienDP: 1985, Spongy degeneration of the central nervous system in two canine littermates. Vet Pathol22: 561–571.
42.
ZhangBHealyPJZhaoY: 1990, Premature translation termination of the pre-E1 alpha subunit of the branched chain alpha-ketoacid dehydrogenase as a cause of maple syrup urine disease in Polled Hereford calves. J Biol Chem265: 2425–2427.
43.
ZhangBWappnerRSBrandtIK: 1990, Sequence of the E1-alpha subunit of branched-chain alpha-ketoacid dehydrogenase in two patients with thiamine-responsive maple syrup urine disease. Am J Hum Genet46: 843–846.
